J. E. Smallshaw, J. A. Richardson, E. S. Vitetta, and . Rivax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol, vol.25, pp.7459-7469, 2007.

E. S. Vitetta, J. E. Smallshaw, E. Coleman, H. Jafri, C. Foster et al., A pilot clinical trial of a recombinant ricin vaccine in normal humans, Proc. Natl. Acad. Sci, vol.103, pp.2268-2273, 2006.

P. V. Lemley, P. Amanatides, and D. C. Wright, Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo, Hybridoma, vol.13, pp.417-421, 1994.

J. Prigent, L. Panigai, P. Lamourette, D. Sauvaire, K. Devilliers et al., Neutralising antibodies against ricin toxin, PLoS One, vol.6, 2011.

V. L. Schramm, Transition state analogues for enzymes of nucleic acid metabolism, Nucleic Acids Res. Suppl, pp.107-108, 2003.

Y. Bai, A. F. Monzingo, and J. D. Robertus, The X-ray structure of ricin A chain with a novel inhibitor, Arch. Biochem. Biophys, vol.483, pp.23-28, 2009.

D. J. Miller, K. Ravikumar, H. Shen, J. K. Suh, S. M. Kerwin et al., Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition, J. Med. Chem, vol.45, pp.90-98, 2002.

X. Yan, T. Hollis, M. Svinth, P. Day, A. F. Monzingo et al., Structure-based identification of a ricin inhibitor, J. Mol. Biol, vol.266, pp.1043-1049, 1997.

M. B. Sturm, S. Roday, and V. L. Schramm, Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design, J. Am. Chem. Soc, vol.129, pp.5544-5550, 2007.

S. Fan, F. Wu, F. Martiniuk, M. L. Hale, A. D. Ellington et al., Protective effects of anti-ricin A-chain RNA aptamer against ricin toxicity, World J. Gastroenterol, vol.14, pp.6360-6365, 2008.

J. R. Hesselberth, D. Miller, J. Robertus, and A. D. Ellington, In vitro selection of RNA molecules that inhibit the activity of ricin A-chain, J. Biol. Chem, vol.275, pp.4937-4942, 2000.

J. D. Robertus, X. Yan, S. Ernst, A. Monzingo, S. Worley et al., Structural analysis of ricin and implications for inhibitor design, Toxicon, vol.34, pp.1325-1334, 1996.

Y. Bai, B. Watt, P. G. Wahome, N. J. Mantis, and J. D. Robertus, Identification of new classes of ricin toxin inhibitors by virtual screening, Toxicon, vol.56, pp.526-534, 2011.

P. G. Wahome, Y. Bai, L. M. Neal, J. D. Robertus, and N. J. Mantis, Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screen, Toxicon, vol.56, pp.313-323, 2010.

B. Stechmann, S. K. Bai, E. Gobbo, R. Lopez, G. Merer et al., Inhibition of retrograde transport protects mice from lethal ricin challenge, Cell, vol.141, pp.231-242, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00509058

J. B. Saenz, T. A. Doggett, and D. B. Haslam, Identification and characterization of small molecules that inhibit intracellular toxin transport, Infect. Immun, vol.75, pp.4552-4561, 2007.

L. Johannes and V. Popoff, Tracing the retrograde route in protein trafficking, Cell, vol.135, pp.1175-1187, 2008.

P. Watson and R. A. Spooner, Toxin entry and trafficking in mammalian cells, Adv. Drug Deliv. Rev, vol.58, pp.1581-1596, 2006.

K. Sandvig, B. Spilsberg, S. U. Lauvrak, M. L. Torgersen, T. G. Iversen et al., Pathways followed by protein toxins into cells, Int. J. Med. Microbiol, vol.293, pp.483-490, 2004.

J. M. Lord, L. M. Roberts, and W. I. Lencer, Entry of protein toxins into mammalian cells by crossing the endoplasmic reticulum membrane: Co-opting basic mechanisms of endoplasmic reticulum-associated degradation, Curr. Top. Microbiol. Immunol, vol.300, pp.149-168, 2005.

L. Zhao and D. B. Haslam, A quantitative and highly sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis, J. Med. Microbiol, vol.54, pp.1023-1030, 2005.

M. P. Nambiar and H. C. Wu, Ilimaquinone inhibits the cytotoxicities of ricin, diphtheria toxin, and other protein toxins in Vero cells, Exp. Cell Res, vol.219, pp.671-678, 1995.

P. A. Takizawa, J. K. Yucel, B. Veit, D. J. Faulkner, T. Deerinck et al., Complete vesiculation of Golgi membranes and inhibition of protein transport by a novel sea sponge metabolite, vol.73, pp.1079-1090, 1993.

P. H. Lu, S. C. Chueh, F. L. Kung, S. L. Pan, Y. C. Shen et al., Ilimaquinone, a marine sponge metabolite, displays anticancer activity via GADD153-mediated pathway, Eur. J. Pharmacol, vol.556, pp.45-54, 2007.

H. S. Radeke, C. A. Digits, R. L. Casaubon, and M. L. Snapper, Interactions of (-)-ilimaquinone with methylation enzymes: Implications for vesicular-mediated secretion, Chem. Biol, vol.6, pp.639-647, 1999.

T. Yoshida, C. C. Chen, M. S. Zhang, and H. C. Wu, Disruption of the Golgi apparatus by brefeldin A inhibits the cytotoxicity of ricin, modeccin, and Pseudomonas toxin, Exp. Cell Res, vol.192, pp.389-395, 1991.

W. L. Thompson, J. P. Scovill, and J. G. Pace, Drugs that show protective effects from ricin toxicity in in vitro protein synthesis assays, Nat. Toxins, vol.3, pp.369-377, 1995.

S. T. Donta, T. K. Tomicic, and A. Donohue-rolfe, Inhibition of Shiga-like toxins by brefeldin A, J. Infect. Dis, vol.171, pp.721-724, 1995.

R. D. Klausner, J. G. Donaldson, and J. Lippincott-schwartz, Brefeldin A: Insights into the control of membrane traffic and organelle structure, J. Cell Biol, vol.116, pp.1071-1080, 1992.

K. Sandvig, K. Prydz, S. H. Hansen, and B. Van-deurs, Ricin transport in brefeldin A-treated cells: Correlation between Golgi structure and toxic effect, J. Cell Biol, vol.115, pp.971-981, 1991.

J. G. Donaldson, D. Finazzi, and R. D. Klausner, Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein, Nature, vol.360, pp.350-352, 1992.

A. Peyroche, B. Antonny, S. Robineau, J. Acker, J. Cherfils et al., Brefeldin A acts to stabilize an abortive ARF-GDP-Sec7 domain protein complex: Involvement of specific residues of the Sec7 domain, Mol. Cell, vol.3, pp.275-285, 1999.

E. Mossessova, R. A. Corpina, and J. Goldberg, Crystal structure of ARF1*Sec7 complexed with Brefeldin A and its implications for the guanine nucleotide exchange mechanism, Mol. Cell, vol.12, pp.1403-1411, 2003.

J. G. Donaldson and A. Honda, Localization and function of Arf family GTPases, Biochem. Soc. Trans, vol.33, pp.639-642, 2005.

J. G. Donaldson, A. Honda, and R. Weigert, Multiple activities for Arf1 at the Golgi complex, Biochim. Biophys. Acta, vol.1744, pp.364-373, 2005.

J. S. Bonifacino and B. S. Glick, The mechanisms of vesicle budding and fusion, Cell, vol.116, pp.153-166, 2004.

M. S. Robinson, Adaptable adaptors for coated vesicles, Trends Cell Biol, vol.14, pp.167-174, 2004.

T. K. Niu, A. C. Pfeifer, J. Lippincott-schwartz, and C. L. Jackson, Dynamics of GBF1, a Brefeldin A-sensitive Arf1 exchange factor at the Golgi, Mol. Biol. Cell, vol.16, pp.1213-1222, 2005.

J. B. Saenz, W. J. Sun, J. W. Chang, J. Li, B. Bursulaya et al., Golgicide A reveals essential roles for GBF1 in Golgi assembly and function, Nat. Chem. Biol, vol.5, pp.157-165, 2009.

Y. Feng, S. Yu, T. K. Lasell, A. P. Jadhav, E. Macia et al., Exo1: A new chemical inhibitor of the exocytic pathway, Proc. Natl. Acad. Sci, vol.100, pp.6469-6474, 2003.

J. C. Yarrow, Y. Feng, Z. E. Perlman, T. Kirchhausen, and T. J. Mitchison, Phenotypic screening of small molecule libraries by high throughput cell imaging, Comb. Chem. High. Throughput Screen, vol.6, pp.279-286, 2003.

Y. Feng, A. P. Jadhav, C. Rodighiero, Y. Fujinaga, T. Kirchhausen et al., Retrograde transport of cholera toxin from the plasma membrane to the endoplasmic reticulum requires the trans-Golgi network but not the Golgi apparatus in Exo2-treated cells, EMBO Rep, vol.5, pp.596-601, 2004.

R. A. Spooner, P. Watson, D. C. Smith, F. Boal, M. Amessou et al., The secretion inhibitor Exo2 perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi network, Biochem. J, vol.414, pp.471-484, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00478957

F. Boal, L. Guetzoyan, R. B. Sessions, M. Zeghouf, R. A. Spooner et al., LG186: An inhibitor of GBF1 function that causes Golgi disassembly in human and canine cells, Traffic, vol.11, pp.1537-1551, 2010.

L. J. Guetzoyan, R. A. Spooner, F. Boal, D. J. Stephens, J. M. Lord et al., Fine tuning Exo2, a small molecule inhibitor of secretion and retrograde trafficking pathways in mammalian cells, Mol. Biosyst, vol.6, pp.2030-2038, 2010.

L. J. Guetzoyan, R. A. Spooner, J. M. Lord, L. M. Roberts, and G. J. Clarkson, Simple oxidation of pyrimidinylhydrazones to triazolopyrimidines and their inhibition of Shiga toxin trafficking, Eur. J. Med. Chem, vol.45, pp.275-283, 2010.

F. Mallard and L. Johannes, Shiga toxin B-subunit as a tool to study retrograde transport, Methods Mol. Med, vol.73, pp.209-220, 2003.

S. E. Ong, M. Schenone, A. A. Margolin, X. Li, K. Do et al., Identifying the proteins to which small-molecule probes and drugs bind in cells, Proc. Natl. Acad. Sci, vol.106, pp.4617-4622, 2009.

N. Kley, Chemical dimerizers and three-hybrid systems: Scanning the proteome for targets of organic small molecules, Chem. Biol, vol.11, pp.599-608, 2004.

F. Becker, K. Murthi, C. Smith, J. Come, N. Costa-roldan et al., A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors, Chem. Biol, vol.11, pp.211-223, 2004.

B. Lomenick, R. W. Olsen, and J. Huang, Identification of direct protein targets of small molecules, ACS Chem. Biol, vol.6, pp.34-46, 2011.

D. J. Maly, I. C. Choong, and J. A. Ellman, Combinatorial target-guided ligand assembly: Identification of potent subtype-selective c-Src inhibitors, Proc. Natl. Acad. Sci, vol.97, pp.2419-2424, 2000.

D. S. Sem, B. Bertolaet, B. Baker, E. Chang, A. D. Costache et al., Systems-based design of bi-ligand inhibitors of oxidoreductases: Filling the chemical proteomic toolbox, Chem. Biol, vol.11, pp.185-194, 2004.

C. A. Lipinski, F. Lombardo, B. W. Dominy, and P. J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev, vol.46, pp.3-26, 2001.